Precision Medicine and Pharmacogenomics in Community and Primary Care Settings

Activity Preview

Over the last 50 years, the scientific and medical community has seen the field of pharmacogenomics and precision medicine grow from concept to developing research discipline to an integral part of medical practice and application. Pharmacogenomics will be the facet of clinical genomics that will eventually touch every patient in clinical practice. 

Learning Objectives

At the completion of this activity, the pharmacist will be able to:

1. Identify the three approaches to implementing pharmacogenetic testing for patients.
2. Describe the workflow within each model of approach to implementing pharmacogenetic testing.
3. List important questions to ask a pharmacogenetic laboratory to determine if they have the training, programs, and infrastructure to be a "good fit" to meet the goals of your pharmacogenetic program.
4. Name at least five drug-gene implications that are mostly applicable to the community and primary care settings today.
5. Use resources with evidence-based guidelines to support your recommendations to patients and other health professionals.
6. Identify at least three challenges for developing a sustainable model for the practice of pharmacogenetics to support the pharmacist's role in this innovative field.

Activity type: Knowledge-based

Target Audience: Pharmacists 

Learning level: 1

Accreditation Information

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This activity is approved for 2.0 contact hours of CPE credit (0.20 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-18-128-H04-P.

To obtain credit for "Precision Medicine and Pharmacogenomics in Community and Primary Care Settings," complete the assessment with a grade of 70% or better, complete the evaluation, and then claim credit. Participants need to have a valid username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.

APhA's continuing pharmacy education policy allows two opportunities to successfully complete the continuing pharmacy education assessment. Please note that the questions may not appear in the same order as printed and only two attempts to pass the assessmemt will be granted.  The current policy of the APhA Education Department is to not release the correct answers to any of our CPE tests. This policy is intended to maintain the integrity of the CPE activity and the assessment.

Initial release date: February 1, 2018
Expiration date: February 1, 2021 - NO CREDIT GRANTED AFTER THIS DATE


"Precision Medicine and Pharmacogenomics in Community and Primary Care Settings” is a home-study continuing education activity for pharmacists developed by the American Pharmacists Association.

Advisory Board

Amina Abubakar, PharmD, AAHIVP, CEO, Rx Clinic Pharmacy, 7308 Independence Blvd,. Suite I, Charlotte, NC 28227;

Olivia Bentley, PharmD, CFts, AAHIVP, Director of Ambulatory Care Services, Rx Clinic Pharmacy, Charlotte, NC

Susan Kokura, PharmD, Corporate Clinical Pharmacy Manager, Department of Pharmacy, NewYork-Presbyterian Hospital, New York, NY


Amina Abubakar, PharmD, AAHIVP; Olivia Bentley, PharmD, CFts, AAHIVP; Susan Kokura, PharmD; and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For complete staff disclosures, please see the Education and Accreditation Information section at


There is no fee associated with this activity for members of the American Pharmacists Association. There is a $25 fee for nonmembers.

System Requirements

Computer and internet access are required to complete this activity.  Please visit our website and view the Technology System Requirements to have a positive learning experience.

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE# 0202-0000-18-128-H04-P 0.2 CEUs February 01, 2018 - February 01, 2021